Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CASP6 | P55212 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8589719 | 0.95 | ACHE (0.42) | ACHECYP1A1CYP1B1PDK2KDM4E | |
| SCHEMBL510419 | 0.77 | FFAR1 (0.46) | CYP1A1CYP1B1TSHR | |
| SCHEMBL63159 | 0.76 | ACHE (0.62) | ACHEKDM4ECASP6TSHR | |
| SCHEMBL16950926 | 0.75 | ACHE (0.30) | ACHE | |
| SCHEMBL14962453 | 0.75 | CYP2A6 (0.40) | — | |
| SCHEMBL31490567 | 0.74 | CYP1A1 (0.33) | CYP1A1CYP1B1TSHR | |
| SCHEMBL4693793 | 0.74 | GRM5 (0.42) | ACHEKDM4ECASP6TSHR | |
| SCHEMBL138492 | 0.74 | ACHE (0.42) | ACHEKDM4ECASP6TSHR | |
| SCHEMBL516512 | 0.74 | TSHR (0.43) | TSHR | |
| SCHEMBL14012242 | 0.70 | ACHE (0.39) | ACHEKDM4ECASP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025082283-A1 | LIGAND COMPOUND OF CYCLOPEPTIDE STRUCTURE, NUCLIDE MARKER THEREOF, PHARMACEUTICAL COMPOSITION, AND USE | 四川科伦博泰生物医药股份有限公司 | 2025-04-24 | — | — | WO | disclosed |
| CN-114195989-B | Top anti-reflection coating polymer with trapezoid structure, top anti-reflection coating composition and preparation method thereof | 福建泓光半导体材料有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-114195989-A | Top anti-reflection coating polymer with trapezoidal structure, top anti-reflection coating composition and preparation method thereof | 福建泓光半导体材料有限公司 | 2022-03-18 | — | — | CN | disclosed |
| WO-2020025066-A1 | COMPOSITIONS AND METHODS FOR DETECTION AND IMAGING OF AMYLOID FIBRILS, AMYLOID PLAQUES, RNA, AND NUCLEOLI | THE UNIVERSITY OF HONG KONG (CN) | 2020-02-06 | — | — | WO | disclosed |
| US-20180094017-A1 | OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE CONSTRUCT USING THE SAME, AND METHODS FOR PRODUCING THEM | GIFU UNIVERSITY (JP) | 2018-04-05 | — | — | US | disclosed |
| US-20180094017-A1 | OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE CONSTRUCT USING THE SAME, AND METHODS FOR PRODUCING THEM | GIFU UNIVERSITY (JP) | 2018-04-05 | — | — | US | disclosed |
| WO-2016152980-A1 | OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE CONSTRUCT USING SAME, AND METHODS FOR PRODUCING THESE | 国立大学法人岐阜大学 | 2016-09-29 | — | — | WO | disclosed |
| WO-2016152980-A1 | OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE CONSTRUCT USING SAME, AND METHODS FOR PRODUCING THESE | 国立大学法人岐阜大学 | 2016-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180094017-A1 | OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE CONSTRUCT USING THE SAME, AND METHODS FOR PRODUCING THEM | APOB, TTPA, AOX1 | ACHE 4564/4885CYP1A1 4250/4885CYP1B1 3701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.